Novel Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof

A compound having the following general formula (I):

• in which:
• R1 is a radical of structure (a) or of structure (b):
• wherein R5, R6 and R7 are as defined below;
• R2 is a lower alkyl radical having 1 to 5 carbon atoms;
• R3 is a lower alkyl radical having 1 to 5 carbon atoms;
• R4 is a radical of structure (c), bound by a single bond to the cyclohexane from which it depends:
• or R4 is an oxygen atom bound by a double bond to the cyclohexane from which it depends;
• R5 is a hydrogen atom or a methyl radical or a trifluoromethyl radical;
• and
• R6 and R7 represent, independently of one another, a hydrogen atom or a trifluoromethyl radical, or salt or isomer thereof.